Ordered weighted average based grouping of nanomaterials with Arsinh and dose response similarity models.

A Zabeo, G Basei, G Tsiliki, WJGM Peijnenburg, D Hristozov23-12-2021

Tijdschriftartikel

Four aspects affecting health economic decision models and their validation

T Feenstra, I Corro-Ramos, D Hamerlijnck, G van Voorn, S Ghabri23-12-2021

Tijdschriftartikel

A common framework for using and reporting consumer purchase data (CPD) in foodborne outbreak investigations in Europe.

S Jore, UC Braae, Trier Møller, I Friesema, K Paranthaman, K Jalava, et al.23-12-2021

Tijdschriftartikel

Effects of natural organic matter on the joint toxicity and accumulation of Cu nanoparticles and ZnO nanoparticles in Daphnia magna

Q Yu, Z Wang, G Wang, WJGM Peijnenburg, MG Vijver23-12-2022

Tijdschriftartikel

Exploring structural uncertainty and impact of health state utility values on lifetime outcomes in diabetes economic simulation models: findings from the Ninth Mount Hood Diabetes quality-of-life challenge.

M Tew, M Willis, C Asseburg, H Bennett, A Brennan, T Feenstra, et al.23-12-2021

Tijdschriftartikel

Potential of concentration-response data to broaden regulatory application of in vitro test guidelines

MN Jacobs, J Ezendam, B Hakkert, M Oelgeschlaeger15-12-2021

Tijdschriftartikel

"Please, you go first!" preferences for a COVID-19 vaccine among adults in the Netherlands

N Mouter, A de Ruijter, GA de Wit, MS Lambooij, M van Wijhe, J van Exel, R Kessels

Tijdschriftartikel

Long-term exposure to fine particle elemental components and mortality in Europe: Results from six European administrative cohorts within the ELAPSE project

S Rodopoulou, M Stafoggia, J Chen, K de Hoogh, M Bauwelinck, JO Klompmaker, et al.15-12-2021

Tijdschriftartikel

Corrigendum to 'Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL' [Journal of Clinical Virology 141 (2021) 104909]

N van der Moeren, VF Zwart, G Goderski, G Rijkers, W van den Bijllaardt, A Meijer, et al.15-12-2021

Tijdschriftartikel

Delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: specialist care, medication utilization and expenditures 2016-2018

RJ Geurten, JN Struijs, AM Elissen, HJG Bilo, C van Tilburg, D Ruwaard15-12-2021

Tijdschriftartikel